TickerFacts.

Stereotaxis, Inc. (STXS): R&D Expense

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2017-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$9.38M
Year ended 2025-12-31
$10.04M
Trailing 12 months to 2026-06-30
-3.9%
3-year compound annual growth
+2.9%
5-year compound annual growth
$14.26M2009-12-31: $14.26M2010-12-31: $12.24M2011-12-31: $12.89M2012-12-31: $8.41M2013-12-31: $5.67M2014-12-31: $5.16M2015-12-31: $6.25M2016-12-31: $5.49M2017-12-31: $6.70M2018-12-31: $8.22M2019-12-31: $9.02M2020-12-31: $8.14M2021-12-31: $10.20M2022-12-31: $10.56M2023-12-31: $10.27M2024-12-31: $9.76M2025-12-31: $9.38M$9.38M
2009-12-31 R&D Expense (USD) 2025-12-31
Period endedR&D ExpenseChange YoYSource filing
2025-12-31$9.38M-3.9%2026-03-12, From 2025-01-01
2024-12-31$9.76M-5.0%2026-03-12, From 2024-01-01
2023-12-31$10.27M-2.7%2025-03-14, From 2023-01-01
2022-12-31$10.56M+3.5%2024-03-08, From 2022-01-01
2021-12-31$10.20M+25.3%2023-03-09, From 2021-01-01
2020-12-31$8.14M-9.8%2022-03-10, From 2020-01-01
2019-12-31$9.02M+9.8%2021-03-12, From 2019-01-01
2018-12-31$8.22M+22.6%2020-03-16, From 2018-01-01
2017-12-31$6.70Mn/c2019-03-15, From 2017-01-01
2016-12-31$5.49M-12.2%2018-03-20, From 2016-01-01
2015-12-31$6.25M+21.2%2017-03-16, From 2015-01-01
2014-12-31$5.16M-9.1%2016-03-11, From 2014-01-01
2013-12-31$5.67M-32.5%2015-03-16, From 2013-01-01
2012-12-31$8.41M-34.8%2015-03-16, From 2012-01-01
2011-12-31$12.89M+5.2%2014-03-27, From 2011-01-01
2010-12-31$12.24M-14.1%2013-04-01, From 2010-01-01
2009-12-31$14.26Mn/a2012-03-15, From 2009-01-01

R&D Expense at similar companies

Companies with the same SEC industry code (Electromedical & Electrotherapeutic Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedR&D ExpenseChange YoY
Stereotaxis, Inc. (STXS)2025-12-31$9.38M-3.9%
electroCore, Inc. (ECOR)2024-12-31$2.36M-55.6%
Iridex Corp (IRIX)2026-01-03$3.67M-32.7%
Precision Optics Corporation, Inc. (POCI)2025-06-30$1.16M+17.9%
QT Imaging Holdings, Inc. (QTI)2025-12-31$3.94M+20.5%
Electromed, Inc. (ELMD)2026-06-30$1.31M+31.9%
Hyperfine, Inc. (HYPR)2025-12-31$17.45M-22.4%
CapsoVision, Inc (CV)2025-12-31$18.31M+21.1%
Escalon Medical Corp (ESMC)2025-06-30$753.1K+9.4%

Compare STXS, ECOR, IRIX, POCI side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗